Breaking News Instant updates and real-time market news.

$ECON

Economic Data

/

+

03:05
10/25/21
10/25
03:05
10/25/21
03:05

U.S. Dallas Fed preview

U.S. Dallas Fed preview: analysts expect the Dallas Fed manufacturing index to edge up 1.4 ticks to 6.0 in October, bouncing back slightly from the -4.4 point drop to 4.6 in September. That was the lowest print since the -1.9 from July 2020. The index was at 21.2 a year ago. and was at a cycle high of 37.3 in April. The 6-month outlook declined as well, sliding another -3.6 points to 11.5 after dropping crashing -22 points to 15.1 in August. It is down from 37.3 in June.

$ECON Economic Data
/

+

TODAY'S FREE FLY STORIES

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:26
12/02/21
12/02
08:26
12/02/21
08:26
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

Recommendations
Dave & Buster's price target lowered to $50 from $56 at Truist » 08:25
12/02/21
12/02
08:25
12/02/21
08:25
PLAY

Dave & Buster's

$30.15 /

-2.385 (-7.33%)

Truist analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$30.15 /

-2.385 (-7.33%)

PLAY Dave & Buster's
$30.15 /

-2.385 (-7.33%)

10/05/21 Loop Capital
Dave & Buster's initiated with a Buy at Loop Capital
10/05/21 Loop Capital
Dave & Buster's initiated with a Buy at Loop Capital
09/24/21
Fly Intel: Top five analyst upgrades
09/24/21 Jefferies
Dave & Buster's upgraded to Buy from Hold at Jefferies
PLAY Dave & Buster's
$30.15 /

-2.385 (-7.33%)

PLAY Dave & Buster's
$30.15 /

-2.385 (-7.33%)

PLAY Dave & Buster's
$30.15 /

-2.385 (-7.33%)

Conference/Events
UBS quantitative investment analyst to hold analyst/industry conference call » 08:25
12/02/21
12/02
08:25
12/02/21
08:25

Quantitative Investment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Occidental Petroleum announces cash tender offers of senior notes » 08:24
12/02/21
12/02
08:24
12/02/21
08:24
OXY

Occidental Petroleum

$28.96 /

-0.66 (-2.23%)

Occidental announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

11/30/21 Mizuho
Occidental Petroleum price target raised to $50 from $48 at Mizuho
10/26/21 Mizuho
Occidental Petroleum price target raised to $48 from $39 at Mizuho
10/18/21 Truist
Occidental Petroleum upgraded to Buy at Truist on continued record cash flows
10/18/21 Truist
Occidental Petroleum upgraded to Buy from Hold at Truist
OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

OXY Occidental Petroleum
$28.96 /

-0.66 (-2.23%)

Hot Stocks
17 Education & Technology appoints Minghui Wu to board » 08:24
12/02/21
12/02
08:24
12/02/21
08:24
YQ

17 Education & Technology

$1.74 /

-0.16 (-8.42%)

17 Education &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

07/26/21 BofA
17 Education & Technology downgraded to Underperform from Buy at BofA
07/26/21 BofA
New Oriental Education downgraded to Neutral from Buy at BofA
06/16/21 Morgan Stanley
Morgan Stanley cuts 17 Education & Technology to Underweight on K9-related risk
06/16/21 Morgan Stanley
TAL Education cut to Underweight on K9-related business risk at Morgan Stanley
YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

  • 04
    Dec
YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

YQ 17 Education & Technology
$1.74 /

-0.16 (-8.42%)

Hot Stocks
Medexus clarifies FDA details on NDA resubmission for treosulfan » 08:22
12/02/21
12/02
08:22
12/02/21
08:22
MEDXF

Medexus Pharmaceuticals

$2.36 /

+0.21 (+9.77%)

Medexus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDXF Medexus Pharmaceuticals
$2.36 /

+0.21 (+9.77%)

MEDXF Medexus Pharmaceuticals
$2.36 /

+0.21 (+9.77%)

08/18/21 Canaccord
Medexus Pharmaceuticals downgraded to Hold from Speculative Buy at Canaccord
08/09/21 Canaccord
Medexus Pharmaceuticals downgraded to Speculative Buy from Buy at Canaccord
07/19/21 Roth Capital
Medexus Pharmaceuticals initiated with a Buy at Roth Capital
06/18/21 Canaccord
Medexus Pharmaceuticals price target lowered to C$9 from C$9.50 at Canaccord
Initiation
Decibel Therapeutics initiated with a Buy at JonesTrading » 08:21
12/02/21
12/02
08:21
12/02/21
08:21
DBTX

Decibel Therapeutics

$6.28 /

-0.57 (-8.32%)

, REGN

Regeneron

$630.74 /

-5.67 (-0.89%)

JonesTrading analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBTX Decibel Therapeutics
$6.28 /

-0.57 (-8.32%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

DBTX Decibel Therapeutics
$6.28 /

-0.57 (-8.32%)

11/15/21 H.C. Wainwright
Decibel Therapeutics initiated with a Buy at H.C. Wainwright
11/11/21 Citi
Decibel Therapeutics price target lowered to $20 from $29 at Citi
10/21/21 Baird
Baird starts Decibel at Outperform, sees 'number of ways to win'
10/21/21 Baird
Decibel Therapeutics initiated with an Outperform at Baird
REGN Regeneron
$630.74 /

-5.67 (-0.89%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
REGN Regeneron
$630.74 /

-5.67 (-0.89%)

  • 12
    Feb
REGN Regeneron
$630.74 /

-5.67 (-0.89%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

DBTX Decibel Therapeutics
$6.28 /

-0.57 (-8.32%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

Hot Stocks
Delcath Systems announces phase 3 FOCUS study results for Hepzato » 08:21
12/02/21
12/02
08:21
12/02/21
08:21
DCTH

Delcath Systems

$9.79 /

+0.29 (+3.05%)

Delcath Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCTH Delcath Systems
$9.79 /

+0.29 (+3.05%)

DCTH Delcath Systems
$9.79 /

+0.29 (+3.05%)

06/08/21 Roth Capital
Delcath Systems data suggest approvability, says Roth Capital
04/06/21 Roth Capital
Delcath Systems price target raised to $25 from $20 at Roth Capital
03/09/21 Canaccord
Delcath Systems initiated with a Buy, $24 target at Canaccord
03/09/21 Canaccord
Delcath Systems initiated with a Buy at Canaccord
DCTH Delcath Systems
$9.79 /

+0.29 (+3.05%)

  • 09
    Dec
DCTH Delcath Systems
$9.79 /

+0.29 (+3.05%)

Hot Stocks
Kroger jumps 6% to $42.80 after Q3 results beat estimates, FY21 guidance raised  08:20
12/02/21
12/02
08:20
12/02/21
08:20
KR

Kroger

$40.21 /

-1.34 (-3.23%)

 
ShowHide Related Items >><<
KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
09/16/21 MKM Partners
Albertsons price target raised to $27 from $17 at MKM Partners
09/13/21 BMO Capital
Kroger price target raised to $39 from $36 at BMO Capital
09/13/21 MKM Partners
Kroger price target raised to $44 from $40 at MKM Partners
KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

Hot Stocks
Freshworks helps 7-Eleven improve omnichannel customer experience » 08:20
12/02/21
12/02
08:20
12/02/21
08:20
FRSH

Freshworks

$30.92 /

-4.275 (-12.15%)

Freshworks has helped…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRSH Freshworks
$30.92 /

-4.275 (-12.15%)

FRSH Freshworks
$30.92 /

-4.275 (-12.15%)

11/03/21 Piper Sandler
Freshworks price target raised to $53 from $50 at Piper Sandler
10/18/21
Fly Intel: Top five analyst initiations
10/18/21 BofA
Freshworks initiated with a Neutral at BofA
10/18/21 Needham
Freshworks initiated with a Buy at Needham
FRSH Freshworks
$30.92 /

-4.275 (-12.15%)

  • 22
    Sep
FRSH Freshworks
$30.92 /

-4.275 (-12.15%)

FRSH Freshworks
$30.92 /

-4.275 (-12.15%)

Hot Stocks
Enphase Energy announces participation in APS grid services program » 08:18
12/02/21
12/02
08:18
12/02/21
08:18
ENPH

Enphase Energy

$237.27 /

-12.93 (-5.17%)

Enphase Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$237.27 /

-12.93 (-5.17%)

ENPH Enphase Energy
$237.27 /

-12.93 (-5.17%)

11/22/21 Wells Fargo
Enphase Energy initiated with an Overweight at Wells Fargo
11/18/21 BMO Capital
Enphase Energy price target raised to $284 from $220 at BMO Capital
11/18/21 Citi
Enphase Energy price target raised to $315 from $231 at Citi
11/17/21 Truist
Enphase Energy price target raised to $290 from $250 at Truist
ENPH Enphase Energy
$237.27 /

-12.93 (-5.17%)

ENPH Enphase Energy
$237.27 /

-12.93 (-5.17%)

ENPH Enphase Energy
$237.27 /

-12.93 (-5.17%)

Hot Stocks
Exela Technologies announces extension of early tender time, expiration time » 08:18
12/02/21
12/02
08:18
12/02/21
08:18
XELA

Exela Technologies

$1.15 /

-0.125 (-9.84%)

Exela Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XELA Exela Technologies
$1.15 /

-0.125 (-9.84%)

XELA Exela Technologies
$1.15 /

-0.125 (-9.84%)

11/09/21 B. Riley
Exela Technologies price target lowered to $3 from $4 at B. Riley
08/31/21 B. Riley
Exela Technologies initiated with a Buy at B. Riley
06/02/21 Cantor Fitzgerald
Exela Technologies initiated with an Overweight at Cantor Fitzgerald
XELA Exela Technologies
$1.15 /

-0.125 (-9.84%)

XELA Exela Technologies
$1.15 /

-0.125 (-9.84%)

XELA Exela Technologies
$1.15 /

-0.125 (-9.84%)

Initiation
Enovix initiated with a Buy at Craig-Hallum » 08:17
12/02/21
12/02
08:17
12/02/21
08:17
ENVX

Enovix

$33.02 /

-1.98 (-5.66%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENVX Enovix
$33.02 /

-1.98 (-5.66%)

ENVX Enovix
$33.02 /

-1.98 (-5.66%)

11/09/21 Oppenheimer
Enovix price target raised to $38 from $32 at Oppenheimer
08/16/21 Oppenheimer
Oppenheimer starts 'pioneer' Enovix with Outperform, $32 target
08/16/21 Oppenheimer
Enovix initiated with an Outperform at Oppenheimer
ENVX Enovix
$33.02 /

-1.98 (-5.66%)

Recommendations
Arbutus Biopharma price target raised to $5.50 from $5 at Chardan » 08:16
12/02/21
12/02
08:16
12/02/21
08:16
ABUS

Arbutus Biopharma

$4.60 /

+1.4 (+43.75%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

Hot Stocks
Global Blood Therapeutics provides $400,000 grant to ASH RC » 08:15
12/02/21
12/02
08:15
12/02/21
08:15
GBT

Global Blood Therapeutics

$27.14 /

-1.16 (-4.10%)

The ASH Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

Recommendations
Descartes Systems price target raised to $100 from $95 at RBC Capital » 08:15
12/02/21
12/02
08:15
12/02/21
08:15
DSGX

Descartes Systems

$78.36 /

-1.885 (-2.35%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSGX Descartes Systems
$78.36 /

-1.885 (-2.35%)

DSGX Descartes Systems
$78.36 /

-1.885 (-2.35%)

05:50 Today Barclays
Descartes Systems price target raised to $90 from $89 at Barclays
09/10/21 Canaccord
Descartes Systems price target raised to $90 from $74
09/09/21 RBC Capital
Descartes Systems price target raised to $95 from $85 at RBC Capital
09/09/21 TD Securities
Descartes Systems price target raised to $95 from $80 at TD Securities
DSGX Descartes Systems
$78.36 /

-1.885 (-2.35%)

DSGX Descartes Systems
$78.36 /

-1.885 (-2.35%)

Hot Stocks
Olink participates in proteomics study for heart failure treatment options » 08:15
12/02/21
12/02
08:15
12/02/21
08:15
OLK

Olink

$19.84 /

-1.22 (-5.79%)

Olink Holding announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLK Olink
$19.84 /

-1.22 (-5.79%)

OLK Olink
$19.84 /

-1.22 (-5.79%)

11/11/21 SVB Leerink
Olink price target lowered to $40 from $50 at SVB Leerink
04/19/21 SVB Leerink
SVB Leerink bullish on Olink, initiates with an Outperform
04/19/21 SVB Leerink
Olink initiated with an Outperform at SVB Leerink
04/19/21 BTIG
Olink initiated with a Buy at BTIG
OLK Olink
$19.84 /

-1.22 (-5.79%)

  • 15
    Jul
  • 25
    Mar
OLK Olink
$19.84 /

-1.22 (-5.79%)

Conference/Events
Federal Reserve Bank of Atlanta President participates in a webinar » 08:15
12/02/21
12/02
08:15
12/02/21
08:15

Federal Reserve Bank of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Cocrystal Pharma to discuss progress with COVID-19 antiviral programs » 08:14
12/02/21
12/02
08:14
12/02/21
08:14
COCP

Cocrystal Pharma

/

+

Cocrystal Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COCP Cocrystal Pharma
/

+

COCP Cocrystal Pharma
/

+

06/15/21 H.C. Wainwright
Cocrystal Pharma price target lowered to $4 from $4.50 at H.C. Wainwright
COCP Cocrystal Pharma
/

+

Conference/Events
Silgan Holdings management to meet virtually with Loop Capital » 08:13
12/02/21
12/02
08:13
12/02/21
08:13
SLGN

Silgan Holdings

$41.07 /

-0.43 (-1.04%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$41.07 /

-0.43 (-1.04%)

SLGN Silgan Holdings
$41.07 /

-0.43 (-1.04%)

11/24/21
Fly Intel: Top five analyst initiations
11/24/21 Raymond James
Silgan initiated with Outperform, $47 target at Raymond James
11/23/21 Raymond James
Silgan Holdings initiated with an Outperform at Raymond James
10/28/21 Citi
Silgan Holdings price target raised to $45 from $42 at Citi
SLGN Silgan Holdings
$41.07 /

-0.43 (-1.04%)

Initiation
Canadian National resumed with an Equal Weight at Morgan Stanley » 08:13
12/02/21
12/02
08:13
12/02/21
08:13
CNI

Canadian National

$126.21 /

-0.41 (-0.32%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$126.21 /

-0.41 (-0.32%)

CNI Canadian National
$126.21 /

-0.41 (-0.32%)

11/16/21 Atlantic Equities
Canadian National initiated with a Neutral at Atlantic Equities
10/27/21 CIBC
Canadian National downgraded to Neutral on valuation at CIBC
10/27/21 CIBC
Canadian National downgraded to Neutral from Outperformer at CIBC
10/25/21 BMO Capital
Canadian National price target raised to C$170 from C$160 at BMO Capital
CNI Canadian National
$126.21 /

-0.41 (-0.32%)

CNI Canadian National
$126.21 /

-0.41 (-0.32%)

CNI Canadian National
$126.21 /

-0.41 (-0.32%)

CNI Canadian National
$126.21 /

-0.41 (-0.32%)

Recommendations
Vertex Pharmaceuticals price target raised to $265 from $250 at RBC Capital » 08:12
12/02/21
12/02
08:12
12/02/21
08:12
VRTX

Vertex Pharmaceuticals

$204.99 /

+18 (+9.63%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$204.99 /

+18 (+9.63%)

VRTX Vertex Pharmaceuticals
$204.99 /

+18 (+9.63%)

12/01/21 Stifel
Vertex Pharmaceuticals APOL1 clinical data looks strong, says Stifel
12/01/21 Piper Sandler
Vertex Phase 2 data an 'incremental positive,' says Piper Sandler
11/18/21 BMO Capital
Vertex Pharmaceuticals initiated with a Market Perform at BMO Capital
11/18/21 Piper Sandler
Vertex downgraded to Neutral at Piper ahead of AbbVie CF data
VRTX Vertex Pharmaceuticals
$204.99 /

+18 (+9.63%)

VRTX Vertex Pharmaceuticals
$204.99 /

+18 (+9.63%)

VRTX Vertex Pharmaceuticals
$204.99 /

+18 (+9.63%)

Hot Stocks
Merus announces poster presentation on MCLA-145 at ESMO-IO » 08:12
12/02/21
12/02
08:12
12/02/21
08:12
MRUS

Merus

$24.99 /

-0.94 (-3.63%)

, INCY

Incyte

$64.88 /

-2.75 (-4.07%)

Merus (MRUS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRUS Merus
$24.99 /

-0.94 (-3.63%)

INCY Incyte
$64.88 /

-2.75 (-4.07%)

MRUS Merus
$24.99 /

-0.94 (-3.63%)

11/17/21
Fly Intel: Top five analyst initiations
11/17/21 Guggenheim
Merus assumed with a Buy at Guggenheim
11/12/21 H.C. Wainwright
Merus price target raised to $45 from $30 at H.C. Wainwright
10/11/21 Citi
Merus price target raised to $38 from $31 at Citi
INCY Incyte
$64.88 /

-2.75 (-4.07%)

11/18/21 BMO Capital
Incyte initiated with a Market Perform at BMO Capital
10/15/21 Cantor Fitzgerald
Incyte price target lowered to $79 from $104 at Cantor Fitzgerald
10/04/21 Truist
Incyte price target lowered to $95 from $120 at Truist
09/28/21 B. Riley
Syndax collaboration 'significant vote of confidence,' says B. Riley
MRUS Merus
$24.99 /

-0.94 (-3.63%)

INCY Incyte
$64.88 /

-2.75 (-4.07%)

  • 05
    Nov
  • 21
    Jan
MRUS Merus
$24.99 /

-0.94 (-3.63%)

INCY Incyte
$64.88 /

-2.75 (-4.07%)

MRUS Merus
$24.99 /

-0.94 (-3.63%)

INCY Incyte
$64.88 /

-2.75 (-4.07%)

Hot Stocks
Kroger reports Q3 gross margin 21.66% of sales » 08:11
12/02/21
12/02
08:11
12/02/21
08:11
KR

Kroger

$40.21 /

-1.34 (-3.23%)

Gross margin was 21.66%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
09/16/21 MKM Partners
Albertsons price target raised to $27 from $17 at MKM Partners
09/13/21 BMO Capital
Kroger price target raised to $39 from $36 at BMO Capital
09/13/21 MKM Partners
Kroger price target raised to $44 from $40 at MKM Partners
KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

KR Kroger
$40.21 /

-1.34 (-3.23%)

Hot Stocks
Quanta's Medolife Rx announces results of study of CBD-based Muscle Rub » 08:11
12/02/21
12/02
08:11
12/02/21
08:11
QNTA

Quanta

/

+

Medolife Rx announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QNTA Quanta
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.